GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | +100.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | -54.5% | 44 | -63.3% | 0.00% | -50.0% |
| Q1 2020 | $11,000 | -42.1% | 120 | -35.5% | 0.00% | -33.3% |
| Q4 2019 | $19,000 | -9.5% | 186 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | -34.4% | 186 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $32,000 | +3.2% | 186 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $31,000 | +72.2% | 186 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $18,000 | -43.8% | 186 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $32,000 | +23.1% | 186 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $26,000 | +13.0% | 186 | -10.6% | 0.01% | +20.0% |
| Q1 2018 | $23,000 | +283.3% | 208 | +372.7% | 0.01% | +150.0% |
| Q4 2017 | $6,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |